发明申请
- 专利标题: Quinoline 3-Sulfonate Esters as Nk3 Receptor Modulators
- 专利标题(中): 喹啉-3-磺酸酯作为Nk3受体调节剂
-
申请号: US11917820申请日: 2006-06-21
-
公开(公告)号: US20080194622A1公开(公告)日: 2008-08-14
- 发明人: Thomas R. Simpson , James Kang , Jeffrey S. Albert , Cristobal Alhambra , Gerard M. Koether , James Woods , Yan Li
- 申请人: Thomas R. Simpson , James Kang , Jeffrey S. Albert , Cristobal Alhambra , Gerard M. Koether , James Woods , Yan Li
- 申请人地址: SE Sodertalje
- 专利权人: AstraZeneca AB
- 当前专利权人: AstraZeneca AB
- 当前专利权人地址: SE Sodertalje
- 国际申请: PCT/SE06/00758 WO 20060621
- 主分类号: A61K31/47
- IPC分类号: A61K31/47 ; C07D215/00 ; A61P25/00 ; A61P29/00 ; A61P5/00 ; A61P35/00
摘要:
Compounds of Formula I wherein R1, A, R2, R3, R4, R5 n, m and q are as described in the specification, pharmaceutically-acceptable salts, methods of making, pharmaceutical compositions containing and methods for using the same.